HUT63411A - Process for producing 4-alkyl imidazole derivatives and pharmaceutical compositions comprising same - Google Patents

Process for producing 4-alkyl imidazole derivatives and pharmaceutical compositions comprising same

Info

Publication number
HUT63411A
HUT63411A HU924058A HU405892A HUT63411A HU T63411 A HUT63411 A HU T63411A HU 924058 A HU924058 A HU 924058A HU 405892 A HU405892 A HU 405892A HU T63411 A HUT63411 A HU T63411A
Authority
HU
Hungary
Prior art keywords
producing
same
pharmaceutical compositions
imidazole derivatives
alkyl imidazole
Prior art date
Application number
HU924058A
Other languages
English (en)
Other versions
HU9204058D0 (en
Inventor
David John Carini
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of HU9204058D0 publication Critical patent/HU9204058D0/hu
Publication of HUT63411A publication Critical patent/HUT63411A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
HU924058A 1990-07-13 1991-07-15 Process for producing 4-alkyl imidazole derivatives and pharmaceutical compositions comprising same HUT63411A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55263790A 1990-07-13 1990-07-13
US07/650,258 US5137902A (en) 1990-07-13 1991-02-04 4-alkylimidazole derivatives and anti-hypertensive use thereof

Publications (2)

Publication Number Publication Date
HU9204058D0 HU9204058D0 (en) 1993-03-29
HUT63411A true HUT63411A (en) 1993-08-30

Family

ID=27070086

Family Applications (2)

Application Number Title Priority Date Filing Date
HU924058A HUT63411A (en) 1990-07-13 1991-07-15 Process for producing 4-alkyl imidazole derivatives and pharmaceutical compositions comprising same
HU9204058A HU223530B1 (hu) 1990-07-13 1991-07-15 4-Alkil-imidazol-származékok

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU9204058A HU223530B1 (hu) 1990-07-13 1991-07-15 4-Alkil-imidazol-származékok

Country Status (23)

Country Link
US (1) US5137902A (hu)
EP (1) EP0539509B1 (hu)
JP (1) JP2550455B2 (hu)
KR (1) KR0162669B1 (hu)
AT (1) ATE121087T1 (hu)
AU (1) AU639400B2 (hu)
BG (1) BG61341B1 (hu)
CA (1) CA2087274C (hu)
CZ (1) CZ280018B6 (hu)
DE (1) DE69108913T2 (hu)
DK (1) DK0539509T3 (hu)
ES (1) ES2071325T3 (hu)
FI (1) FI102752B1 (hu)
HU (2) HUT63411A (hu)
IE (1) IE69849B1 (hu)
IL (1) IL98794A (hu)
MY (1) MY140243A (hu)
NO (1) NO303015B1 (hu)
NZ (1) NZ238920A (hu)
PL (1) PL168311B1 (hu)
RO (1) RO111270B1 (hu)
SK (1) SK279326B6 (hu)
WO (1) WO1992000977A2 (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
DE4132633A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Cyclisch substituierte imidazolyl-propensaeurederivate
US5250558A (en) * 1992-01-28 1993-10-05 Merck & Co., Inc. Substituted triazolinones, triazolinethiones, and triazolinimines as neurotensin antagonists used to treat psychosis
US5326776A (en) * 1992-03-02 1994-07-05 Abbott Laboratories Angiotensin II receptor antagonists
GB9218449D0 (en) 1992-08-29 1992-10-14 Boots Co Plc Therapeutic agents
US5310929A (en) * 1992-08-06 1994-05-10 E. I. Du Pont De Nemours And Company Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
NO304429B1 (no) * 1992-12-17 1998-12-14 Sankyo Co Bifenylderivater, farmas°ytisk preparat og deres anvendelse for fremstilling av et medikament for behandling av hypertensjon og hjertesykdom
US5338740A (en) * 1993-07-13 1994-08-16 Pfizer Inc. Angiotensin II receptor antagonists
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
AU2001267404A1 (en) * 2000-05-04 2001-11-12 Ipf Pharmaceuticals Gmbh Novel compounds for the treatment of inflammatory and cardiovascular diseases
CA2568640C (en) 2004-06-04 2011-08-09 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing irbesartan
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
CA2575177A1 (en) * 2004-09-02 2006-03-16 Teva Pharmaceutical Industries Ltd. Purification of olmesartan medoxomil
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2170930B3 (en) 2007-06-04 2013-10-02 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
AU645022B2 (en) * 1989-06-30 1994-01-06 E.I. Du Pont De Nemours And Company Fused-ring aryl substituted imidazoles
AU644802B2 (en) * 1989-06-30 1993-12-23 E.I. Du Pont De Nemours And Company Substituted imidazoles
DE4132633A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Cyclisch substituierte imidazolyl-propensaeurederivate

Also Published As

Publication number Publication date
AU8311691A (en) 1992-02-04
FI102752B (fi) 1999-02-15
IL98794A0 (en) 1992-07-15
KR0162669B1 (ko) 1998-12-01
BG97438A (bg) 1994-03-24
NO303015B1 (no) 1998-05-18
RO111270B1 (ro) 1996-08-30
FI102752B1 (fi) 1999-02-15
CA2087274A1 (en) 1992-01-14
BG61341B1 (en) 1997-06-30
DE69108913D1 (de) 1995-05-18
IE69849B1 (en) 1996-10-02
SK279326B6 (sk) 1998-10-07
US5137902A (en) 1992-08-11
CZ280018B6 (cs) 1995-09-13
MY140243A (en) 2009-12-31
AU639400B2 (en) 1993-07-22
DK0539509T3 (da) 1995-07-03
ES2071325T3 (es) 1995-06-16
PL168311B1 (pl) 1996-02-29
WO1992000977A2 (en) 1992-01-23
JP2550455B2 (ja) 1996-11-06
DE69108913T2 (de) 1995-08-24
EP0539509B1 (en) 1995-04-12
IL98794A (en) 1995-11-27
SK391292A3 (en) 1993-07-07
FI930109A0 (fi) 1993-01-12
IE912438A1 (en) 1992-01-15
ATE121087T1 (de) 1995-04-15
HU9204058D0 (en) 1993-03-29
NO930088L (no) 1993-01-11
PL297616A1 (hu) 1992-07-13
WO1992000977A3 (en) 1992-02-20
NZ238920A (en) 1993-07-27
CA2087274C (en) 2002-02-19
EP0539509A1 (en) 1993-05-05
HU223530B1 (hu) 2004-08-30
FI930109A (fi) 1993-01-12
NO930088D0 (no) 1993-01-11
CZ391292A3 (en) 1993-12-15
JPH05508415A (ja) 1993-11-25

Similar Documents

Publication Publication Date Title
HUT63411A (en) Process for producing 4-alkyl imidazole derivatives and pharmaceutical compositions comprising same
IL124537A0 (en) Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same
TR199902995T2 (xx) 9-Oksim eritromisin t�revleri
DE69317877D1 (en) 4''-deoxyerythromycinderivate
IL96636A0 (en) Piperidine derivatives and pharmaceutical compositions containing them
HU9401951D0 (en) Serotoninergic ergoline derivatives
CA2120229A1 (fr) Derives de methylpiperazinoazepine, leur preparation et leur utilisation
IL87174A (en) Benzimidazole derivatives, their preparation and pharmaceutical compositions containing them
AU562643B2 (en) N-arylpiperazine derivatives
IE821028L (en) Cephem derivatives
GR3030692T3 (en) Erythromycin derivatives
HUT60495A (en) Process for producing ergoline derivatives and pharmaceutical compositions comprising such compounds
IT1262569B (it) Derivati tetraciclici diazepinici, loro processi di preparazione e composizioni farmaceutiche che li contengono
IT1252568B (it) Derivati pirimidinici sostituiti da eteroarili ad attivita' a ii antagonista
IT1254562B (it) Forma cristallina dell'endo-3-etil-2,3-diidro-n-(8-metil-8-azabiciclo (3.2.1) ott-3-il)- 2-oxo-1h-benzimidazolo-1-carbossamide cloridrato